Dan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for his work on one of […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/harvard-gazette.jpg275281Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-09 14:38:152021-08-09 14:38:15Dan Barouch and the birth of the J&J COVID vaccine
“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-06 09:32:512021-08-09 09:33:58New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot.
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/10/wsj.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-06 09:30:142021-08-09 09:31:11J&J Vaccine Highly Effective Against Delta Variant in South African Trial
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/09/AA0O_yzc_400x400.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-21 09:27:142021-07-22 09:38:03We’re Zeroing In On the ‘Holy Grail’ of COVID-19 Immunity
Dan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/ABCNEWS.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-08 13:33:492021-07-09 13:35:32Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer says
The Johnson & Johnson vaccine appears to provide strong protection against the Delta variant that not only doesn’t wane over time but seems to grow stronger. See Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/NPR.png16381638Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-02 08:34:262021-07-02 08:34:26Johnson & Johnson Vaccine Protects Against Delta Variant Of COVID, Study Finds
The Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in […]
Johnson & Johnson announced that its COVID-19 vaccine “”generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The vaccine was developed in […]
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Read Article
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-01 14:19:282021-07-03 14:20:58Johnson & Johnson Vaccine Protects Against Delta Variant, Company Reports
Dan Barouch and the birth of the J&J COVID vaccine
/in NewsDan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for his work on one of […]
New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot.
/in News“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in […]
J&J Vaccine Highly Effective Against Delta Variant in South African Trial
/in NewsStudy finds J&J vaccine has an efficacy of up to 71% against hospitalization from the highly contagious strain. Read Article
We’re Zeroing In On the ‘Holy Grail’ of COVID-19 Immunity
/in News“The more breakthroughs you have, the easier it is to determine,” Katy Stephenson. Read Article
Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer says
/in NewsDan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health […]
Johnson & Johnson Vaccine Protects Against Delta Variant Of COVID, Study Finds
/in NewsThe Johnson & Johnson vaccine appears to provide strong protection against the Delta variant that not only doesn’t wane over time but seems to grow stronger. See Article
J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant, studies find
/in NewsThe Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in […]
J&J coronavirus vaccine appears to protect against Delta variant
/in NewsJohnson & Johnson announced that its COVID-19 vaccine “”generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The vaccine was developed in […]
J&J Covid Shot Neutralizes Delta Variant, Company Says
/in NewsJohnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Read Article
Johnson & Johnson Vaccine Protects Against Delta Variant, Company Reports
/in NewsThe vaccine also produced long-lasting immune responses, researchers said. Booster shots seem unnecessary, at least for now. Read Article